1. Unconventional avenues to decelerate diabetic retinopathy
- Author
-
Brijesh Takkar, Abhishek Sheemar, Rajagopalaboopathi Jayasudha, Deepak Soni, Raja Narayanan, Pradeep Venkatesh, Sisinthy Shivaji, and Taraprasad Das
- Subjects
Blood Glucose ,Ophthalmology ,Diabetic Retinopathy ,Fundus Oculi ,Diabetes Mellitus ,Humans ,Mass Screening ,Vision, Low - Abstract
Diabetic retinopathy (DR) is an important microvascular complication of diabetes mellitus (DM), causing significant visual impairment worldwide. Current gold standards for retarding the progress of DR include blood sugar control and regular fundus screening. Despite these measures, the incidence and prevalence of DR and vision-threatening DR remain high. Given its slowly progressive course and long latent period, opportunities to contain or slow DR before it threatens vision must be explored. This narrative review assesses the recently described unconventional strategies to retard DR progression. These include gut-ocular flow, gene therapy, mitochondrial dysfunction-oxidative stress, stem cell therapeutics, neurodegeneration, anti-inflammatory treatments, lifestyle modification, and usage of phytochemicals. These therapies impact DR directly, while some of them also influence DM control. Most of these strategies are currently in the preclinical stage, and clinical evidence remains low. Nevertheless, our review suggests that these approaches have the potential for human use to prevent the progression of DR.
- Published
- 2022